Disclosure as per Regulation 30 of SEBI LODR Regualtion 2015 for the appointment of Additional Non- Executive & Independent Director.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has appointed Ms. Parul Agrawal (DIN: 11268580) as an Additional Non-Executive & Independent Director of the company with effect from 13th February 2026. The appointment was approved at a board meeting held on 13th February 2026, which ran from 12:15 PM to 12:45 PM. Ms. Agrawal, born on 21/07/1986, is a Company Secretary by profession and is not related to any existing Directors or Key Managerial Personnel of the company. She has also confirmed that she is not debarred from holding the office of director by SEBI or any other authority.
This is a routine board-level appointment that strengthens the independence of the board. It is unlikely to have a material impact on the stock price, though investors may note the addition of a qualified Company Secretary to the independent director slate.